Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference
A live webcast of the presentation will be available on the
About Eiger
Eiger is a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for orphan diseases. We are committed to translational innovation and the repurposing of well-characterized drugs acting on newly identified or novel targets. Our mission is to systematically reduce the time and cost of the drug development process to more rapidly deliver important medicines to patients with orphan diseases. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Investors:
1-650-619-6115, [email protected]
View original content with multimedia:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-present-at-jefferies-2017-healthcare-conference-300554493.html
SOURCE